PROVENTAI N T E R N A T I O N A L
AGENDA ONCOLOGY
TRACK 2 - ONCOLOGY PRECISION MEDICINE / PERSONALISED MEDICINE
TRACK 1 - ONCOLOGYBIOMARKER DISCOVERY
TRACK 4 - ONCOLOGY ANTIBODY DISCOVERY
TRACK 3 - ONCOLOGY COMPANION DIAGNOSTICS
TRACK 6 - ONCOLOGYCLINICAL RESEARCH
TRACK 5 - ONCOLOGY IMMUNO-ONCOLOGY / CHECK POINT INHIBITORS
TRACK 8 - BIOINFORMATICS TRANSLATIONAL MEDICINE & INFORMATICS
TRACK 7 - BIOINFORMATICS GENOMICS
TRACK 10 - BIOINFORMATICS DATA INTEGRATION / DATA MINING
TRACK 9 - BIOINFORMATICS ARTIFICIAL INTELLIGENCE / MACHINE LEARNING
TRACK 12 - BIOINFORMATICSBIG DATA / DATA MANAGEMENT
TRACK 11 - BIOINFORMATICS DATA VISUALISATION
AGENDA BIOINFORMATICS
2019 ATTENDEES
SPONSORS
Click here to find out what our clients think about our Strategy Meetings
Fred Jacobs CEO TYG Oncology
Suzanne Saffie-Siebert CEO SiSaf
Alvaro Costa CEO Alkol Biotech
Soren Bregenholt CEO Macrophage Pharma
Paul Agapow Director Health Informatics AstraZeneca
Wolfgang Hackl Founder OncoGenomX
Steven Zimmer CEO EPICOMBI Therapeutics
Philip Beer Director Tessellex Ltd.
Marcelo Garcia Former Head of Medical SystemNovartis
Geert C. Mudde Founder and CSO TYG Oncology Ltd.
STANSTED
CONTRIBUTORS TO THE AGENDAOUR UNIQUE ONLINE MEETING FORMAT
Roundtable DiscussionsThese interactive and informal discussion groups are the hallmark of the meeting. The brightest minds in the industry are brought together in 60-minute sessions that enable participants from all over the world to share ideas, challenges and lessons learned.
Personalised AgendaEach delegate receives a personalised agenda with the roundtable discussions that you choose. You only attend sessions and meetings that fit your challenges and interests, ensuring your time spent on the online platform is focused and well-utilised.
One-to-one MeetingsThe most effective and time efficient way to assess potential partners at a strategic level. Gain access to our exclusive networking app to identify the people that you need to meet. The app will allow for instant anddirect messaging to organise online meetings during the dedicated time to most benefit you.
Strategic NetworkingStrategic networking opportunities form a key benefit of the meeting. Our new online format for building and strengthening alliances to make lasting connections that benefit you.
http://
2020JUNESTRATEGY 30thONLINE MEETINGBIOINFORMATICSBIOINFORMATICSONCOLOGYONCOLOGY
&
PROVENTAI N T E R N A T I O N A L
1
CO-HOST
GO TO MENU NEXT PAGEPREVIOUS PAGE
BIOINFORMATICSBIOINFORMATICSONCOLOGY
ONCOLOGY
ONTOFORCE empowers data-driven decisions, drives innovation and speeds up cycle time. We unlock and connect siloed data into a linked data fabric. This enables everyone to securely integrate, analyse, and extract data faster, bringing simplicity to complexity. With DISQOVER, ONTOFORCE developed an innovative, self-service, linked data platform that delivers trusted and timely insights for end users.
VISIT WEBSITE
VISIT WEBSITE
VISIT WEBSITE VISIT WEBSITE
VISIT WEBSITE
BioLizard is an expert team of data and bio-engineers dedicated to developing solutionsfor scientific research using bioinformatics, biostatistics, ML and AI. BioLizard transformsscientific data into highly valuable information, providing the necessary solutions to themost pressing questions. Our specialty is gathering a range of expertise tailored-made toour customers’ needs and developing innovative bioinformatics solutions required for even the most complex biological datasets. We implement up-to-date technological tools to assist our customers with their biological data integration, algorithm development, bioinformatics analyses, and pipeline implementation and automation. Importantly, ourprofessionals are also familiar with specific life science expertise.VISIT WEBSITE
PRO-PARTNERS
VISIT WEBSITE VISIT WEBSITEVISIT WEBSITE
Inteliquet is a leading provider of technology, insights and expertise for clinical research, patient treatment, and translational medicine strategies. Our sophisticated, proprietary platform can securely, accurately, and quickly aggregate and analyze healthcare data, helping to ensure clinical trials are designed more effectively, patients are matched to trials more rapidly and patient-care decisions are made using real-world evidence. Our team is passionate about ensuring that every patient—regardless of race, geography, age, sex, economic status, or stage of disease—has access to promising therapies as soon as they become available to help improve the care they, and future generations, receive.
Dotmatics delivers a ready-to-use platform to capture, register, share, collaborate, query, visualise and analyse all the information and knowledge generated in the modern, highly collaborative scientific industries. Dotmatics has significant expertise in scientific informatics, including database management for chemistry and biologics, electronic laboratory notebooks, chemical and biological registration, screening data management, SAR analysis, reporting, and visualisation. The enterprise solutions are flexible, scalable and configurable, providing effective scientific information management across entire organisations, from discovery research to development and early manufacturing.
At Proventa Talent, we always look ahead to ensure that the service we deliver to you is second to none, both now and in the future. Proventa Talent based around our three key principles of commitment, intelligence and partnership ensures an unparalleled recruitment solution in the industry. We work with the leading talent in the field to offer a service of high quality, efficiency and transparency. In addition to this, our relationship with many organisations across the Life Sciences sector means that we are constantly developing our recruitment services to offer market-leading solutions including Contingency, Executive Search, Contract and fully integrated Recruitment Process Outsourcing to suit your short, medium and long term needs.
SPONSORS&
PROVENTAI N T E R N A T I O N A L
2 GO TO MENU NEXT PAGEPREVIOUS PAGE
ROUNDTABLE TOPIC CONFIRMED FOR SPONSOR
ROUNDTABLE TOPIC CONFIRMED FOR SPONSOR
ROUNDTABLE TOPIC CONFIRMED FOR SPONSOR
ROUND TABLE TOPIC CONFIRMED FOR SPONSOR
ROUNDTABLE TOPIC CONFIRMED FOR SPONSOR
KEYNOTE PRESENTATION KEYNOTE PRESENTATIONKEYNOTE PRESENTATION
KEYNOTE PRESENTATION KEYNOTE PRESENTATIONKEYNOTE PRESENTATION
Biomarker discovery and validation: genomics and
beyond
Machine learning informed biomarker selection using multi-omics integration.
Extracellular RNA biomarkers for Oncology - Advantages &
Disadvantages
01 02 03 04 05 06
Precision Oncology - the road ahead from “vaguely right” to “precisely right”
Computational Epigenetics: Advances and challenges
Precison medince: challenges and future
Improve treatment efficacy and reduce patients side effects, through the optimization of
companion diagnosis
Invent new R&D partnership models to accelerate adoption of
companion diagnostics
How do you optimize CDx assays before you have access to stratified
clinical samples?
Antibody engineering considerations for immuno-oncology
ADC’s: Current challanges and opportuinities
Investments for PoC antibody discovery
Disciplined alliance management as a facilitator of successful global
discovery collaborations
How the Immuno-Oncology Therapies Have Changed the Standard of Care in Oncology
Discovery of ImmunoOncology Therapies: Antibody and Virus-based Approaches
BIOMARKER DISCOVERY PRECISION MEDICINE PERSONALISED MEDICINE COMPANION DIAGNOSTICS ANTIBODY DISCOVERY
IMMUNO-ONCOLOGY CHECK POINT INHIBITORS
Wolfgang Hackl - FounderOncoGenomX
Lore Gruenbaum - VP of Biology Gotham Therapeutics
Fatima Ann Sulaiman - Head of Resrc. Scleroderma and Raynaud’s UK
Zahra Jawad - Group Leader Agenus
Soren Bregenholt - CEOMacrophage Pharma
Achim Kless - Scien. Director Grünenthal Group
Lucy Clossick Thomson - DirectorArchilles Therapeutics
Henry Alistair - Head of Discov. Science UCB
Greet C. Mudde - Founder & CSOS-target Therapeutics
CLINICAL RESEARCH
The clinical trial of the future: will AI and Blockchain be a core part of drug
development?
Sridevi Nagarajan - Sr. Director AstraZeneca
Using RWE to speed the Clinical reserach lifecycle and increase
patient engament
Real time Trials: Genomics & small target population
Aleksandra Filipovic - Therapeutic Lead PureTech Health
Prasun Mishra, Ph.D.- Founder and CEO Agility Pharma, MetaImmune Inc. and
American Association for Precision Medicine
12:00 - 12:30
19:20 - 20:20
14:30 - 15:30
18:00 - 19:00
13:30 - 14:30
19:00 - 19:20
12:30 - 13:30
15:30 - 17:30
17:30 - 18:00
TIME ( *G.M.T. )TRACK & ROOM
7:00 - 7:30
14:20 - 15:20
9:30 - 10:30
13:00 - 14:00
8:30 - 9:30
14:00 - 14:20
7:30 - 8:30
10:30 - 12:30
12:30 - 13:00
TIME ( *E.T. )TRACK & ROOM
NETWORKING BREAK1 - 1 MEETING *13:30-13:50 G.M.T. NETWORKING BREAK
1 - 1 MEETING *19:00-19:20 G.M.T.
1 - 1 MEETING *13:50-14:10 G.M.T. 1 - 1 MEETING *14:10-14:30 G.M.T.
1 - 1 MEETING *15:30-15:50 G.M.T. 1 - 1 MEETING *16:10-16:30 G.M.T. 1 - 1 MEETING *16:50-17:10 G.M.T.1 - 1 MEETING *15:50-16:10 G.M.T. 1 - 1 MEETING *16:30-16:50 G.M.T. 1 - 1 MEETING *17:10-17:30 G.M.T.
Dr. Allan Jordan - Director of Oncology
ONCOLOGY
ONCOLOGY AGENDA
PROVENTAI N T E R N A T I O N A L
3
BIOINFORMATICSBIOINFORMATICS
GO TO MENU NEXT PAGEPREVIOUS PAGE
07 08 09 10 11 12
ROUNDTABLE TOPIC CONFIRMED FOR SPONSOR
ROUNDTABLE TOPIC CONFIRMED FOR SPONSOR
ROUND TABLE TOPIC CONFIRMED FOR SPONSOR
ROUNDTABLE TOPIC CONFIRMED FOR SPONSOR
ROUNDTABLE TOPIC CONFIRMED FOR SPONSOR
KEYNOTE PRESENTATION KEYNOTE PRESENTATIONKEYNOTE PRESENTATION
KEYNOTE PRESENTATION KEYNOTE PRESENTATIONKEYNOTE PRESENTATION
How to Improving Drug Development and Clinical trials with Real World
Evidence
Predictive analytics: The leveraging of computational techniques to aide in
decision-making
Improving the efficiency of Clinical trials with real world data
Strategic partnership of AI start-up and Pharma
Foundational concepts for good design thinking, intelligent adaption
and community adoption
AI in drug discovery: challenges and opportunities
Using data analytics to drive innovation and value
The importance of data integration in Clinical Trials; accessibility to data set for reproducibility and
study expansion
Data integration solution, for the improvement of research
How do we gain mechanistic insights from multi-level data
integration?
Integration, Analysis & Visualisation of Biological Data
Making better informed decisions from visualisation and analytic tools
ML for real world: How can big data bring the future of AI into medicine
Big Data for the development of new crop varieties for the biobased markets
Breaking down barriers to AI adoption in health care
TRANSLATIONAL MEDICINE & INFORMATICS AI & MACHINE LEARNING DATA INTEGRATION & DATA MINING DATA VISUALISATION BIG DATA & DATA MANAGEMENT
Paul Agapow - Health Info. Director AstraZeneca
Steven Zimmer - CEO EPICOMBI Therapeutics Ltd.
Rodrigo Lopez - Head of Web Prod. Wellcome Trust Genobe Campus
Emma Laing - Lead Bioinform. Eli Lilly
Minauti Frost - Vice PresidentGSK
Fred Jacobs - CEOTYG-Oncology
David Hamilton - Associate Director Novartis
Vincent Lawton - ChairmanAddex Therapeutics
David Brown - Head of Infrastruc. Genomics England Ltd.
Alvaro Costa - CEOAlkol Bioteck
Chris Penkett - Head of Pipelines Univ. of Cambridge
Tim Van den Bulcke - Head Bioinfo. Galapagos
Bonde Bhushan - Head of IT Solut. UCB
Marcelo Garcia - Former HeadNovartis
GENOMICS
Design & execution of optimal cross-platform translational medicine programmes to
define in-human mechanism of action and identify
therapeutic biomarkers.Philip Beer - Director
Tessellex Ltd.
Bio-Courier Technology as Non-Viral Delivery System for
Gene Therapy.
Suzanne Saffie-Siebert - CEO SiSaf
The Evolving Landscape of Compute for Genomics
Charles Bradshaw - Head of Bioinf. The Gurdon Institute
12:00 - 12:30
19:20 - 20:20
14:30 - 15:30
18:00 - 19:00
13:30 - 14:30
19:00 - 19:20
12:30 - 13:30
15:30 - 17:30
17:30 - 18:00
TIME ( *G.M.T. )TRACK & ROOM
7:00 - 7:30
14:20 - 15:20
9:30 - 10:30
13:00 - 14:00
8:30 - 9:30
14:00 - 14:20
7:30 - 8:30
10:30 - 12:30
12:30 - 13:00
TIME ( *E.T. )TRACK & ROOM
NETWORKING BREAK1 - 1 MEETING *13:30-13:50 G.M.T. NETWORKING BREAK
1 - 1 MEETING *19:00-19:20 G.M.T.
1 - 1 MEETING *13:50-14:10 G.M.T. 1 - 1 MEETING *14:10-14:30 G.M.T.
1 - 1 MEETING *15:30-15:50 G.M.T. 1 - 1 MEETING *16:10-16:30 G.M.T. 1 - 1 MEETING *16:50-17:10 G.M.T.1 - 1 MEETING *15:50-16:10 G.M.T. 1 - 1 MEETING *16:30-16:50 G.M.T. 1 - 1 MEETING *17:10-17:30 G.M.T.
Hans Constandt - FounderWim Van Criekinge - Co-founder
AGENDA
PROVENTAI N T E R N A T I O N A L
4
ONCOLOGY
Lore Gruenbaum VP of Biology
Gotham Therapeutics
Biomarker discovery and validation: genomics and beyond
ROUNDTABLE TOPIC
TIME SLOT (*GMT)
12:00 - 12:30
Achim KlessScientific DirectorGrünenthal Group
Machine learning informed biomarker selection using multi-omics integration.
ROUNDTABLE TOPIC
TIME SLOT (*GMT)18:00 - 19:00
SPEAKER TBC TBC TBC
Biomarkers in Diagnosis: challenges and approaches.
TIME SLOT (*GMT)
14:30 - 15:30
Extracellular RNA biomarkers for Oncology - Advantages &
Disadvantages
ROUNDTABLE TOPIC
TIME SLOT (*GMT)19:20 - 20:20
SPEAKER TBC TBC TBC
SPONSOR ROUNDTABLE TOPIC
GO TO MENU NEXT PAGEPREVIOUS PAGE
LEARN MORE ABOUT OUR SPEAKERS
TRACK 1 BIOMARKER DISCOVERY
PROVENTAI N T E R N A T I O N A L
5
ONCOLOGY
Wolfgang HacklFounder & CEO OncoGenomX
Precision Oncology - the road ahead from “vaguely right” to
“precisely right”.
Lucy Clossick Thomson Director of Clinical
OperationsAchilles Therapeutics
Computational Epigenetics: Advances and challenges.
SPEAKER TBC TBC TBC
Beginning to leverage OMICS / Beyond genomics: The next wave of
innovation in precision medicine.
Precison medince: challenges and future
Prasun Mishra, Ph.D.Founder and CEO
Agility Pharma, MetaImmune Inc. and American Association for
Precision Medicine
GO TO MENU NEXT PAGEPREVIOUS PAGE
ROUNDTABLE TOPIC
TIME SLOT (*GMT)
ROUNDTABLE TOPIC
TIME SLOT (*GMT)
TIME SLOT (*GMT)
ROUNDTABLE TOPIC
TIME SLOT (*GMT)
SPONSOR ROUNDTABLE TOPIC
12:00 - 12:30
18:00 - 19:00
14:30 - 15:30
19:20 - 20:20LEARN MORE ABOUT OUR SPEAKERS
TRACK 2 PRECISION MEDICINE / PERSONALISED MEDICINE
PROVENTAI N T E R N A T I O N A L
6
TRACK 3 COMPANION DIAGNOSTICS
ONCOLOGY
Fatima Ann SulaimanHead of Research & Services Scleroderma & Raynaud’s UK
Improve treatment efficacy and reduce patients side effects, through
the optimization of companion diagnosis.
SPEAKER TBC TBC TBC
Invent new R&D partnership models to accelerate adoption of companion
diagnostics.
SPEAKER TBC TBC TBC
Multiplex companion diagnostics – development to commercialisation.
How do you optimize CDx assays before you have access to stratified
clinical samples?SPEAKER TBC
TBC TBC
GO TO MENU NEXT PAGEPREVIOUS PAGE
ROUNDTABLE TOPIC
TIME SLOT (*GMT)
ROUNDTABLE TOPIC
TIME SLOT (*GMT)
TIME SLOT (*GMT)
ROUNDTABLE TOPIC
TIME SLOT (*GMT)
SPONSOR ROUNDTABLE TOPIC
12:00 - 12:30
18:00 - 19:00
14:30 - 15:30
19:20 - 20:20LEARN MORE ABOUT OUR SPEAKERS
PROVENTAI N T E R N A T I O N A L
7
TRACK 4 ANTIBODY DISCOVERY
ONCOLOGY
Antibody engineering considerations for immuno-oncology
Henry AlistairHead of Discovery Science
UCB
Zahra JawadGroup Leader in
Discovery TechnologyAgenus
ADC’s: Current challanges and opportuinities
SPEAKER TBC TBC TBC
Engineering Better Antibody Therapeutics Using Computational
Approaches.
Investments for PoC antibody discovery.
SPEAKER TBC TBC TBC
GO TO MENU NEXT PAGEPREVIOUS PAGE
ROUNDTABLE TOPIC
TIME SLOT (*GMT)
ROUNDTABLE TOPIC
TIME SLOT (*GMT)
TIME SLOT (*GMT)
ROUNDTABLE TOPIC
TIME SLOT (*GMT)
SPONSOR ROUNDTABLE TOPIC
12:00 - 12:30
18:00 - 19:00
14:30 - 15:30
19:20 - 20:20LEARN MORE ABOUT OUR SPEAKERS
PROVENTAI N T E R N A T I O N A L
8
TRACK 5 IMMUNO-ONCOLOGY / CHECK POINT INHIBITORS
ONCOLOGY
Soren BregenholtCEO
Macrophage Pharma
Disciplined alliance management as a facilitator of successful global
discovery collaborations.
Geert C. MuddeFounder & CSO
TYG Oncology Ltd.
How the Immuno-Oncology Therapies Have Changed the
Standard of Care in Oncology.
SPEAKER TBC TBC TBC
How an integrated drug discovery approach can better support cancer
immunotherapy.
Discovery of ImmunoOncology Therapies: Antibody and Virus-based
Approaches.Aleksandra FilipovicTherapeutic Lead for
Oncology PureTech Health
GO TO MENU NEXT PAGEPREVIOUS PAGE
ROUNDTABLE TOPIC
TIME SLOT (*GMT)
ROUNDTABLE TOPIC
TIME SLOT (*GMT)
TIME SLOT (*GMT)
ROUNDTABLE TOPIC
TIME SLOT (*GMT)
SPONSOR ROUNDTABLE TOPIC
12:00 - 12:30
18:00 - 19:00
14:30 - 15:30
19:20 - 20:20LEARN MORE ABOUT OUR SPEAKERS
PROVENTAI N T E R N A T I O N A L
9
TRACK 6 CLINICAL RESEARCH
ONCOLOGY
Sridevi Nagarajan Senior Director,
Knowledge Management AstraZeneca
The clinical trial of the future: will AI and Blockchain be a core part
of drug development?
SPEAKER TBC TBC TBC
Using RWE to speed the Clinical reserach lifecycle and increase
patient engament
SPEAKER TBC TBC TBC
Liquid Biopsies in Oncology Clinical Trials: Present and Future
Real time Trials: Genomics and small target
population.SPEAKER TBC
TBC TBC
GO TO MENU NEXT PAGEPREVIOUS PAGE
ROUNDTABLE TOPIC
TIME SLOT (*GMT)
ROUNDTABLE TOPIC
TIME SLOT (*GMT)
TIME SLOT (*GMT)
ROUNDTABLE TOPIC
TIME SLOT (*GMT)
SPONSOR ROUNDTABLE TOPIC
12:00 - 12:30
18:00 - 19:00
14:30 - 15:30
19:20 - 20:20LEARN MORE ABOUT OUR SPEAKERS
PROVENTAI N T E R N A T I O N A L
10
BIOINFORMATICS
TRACK 7 GENOMICS
Philip BeerDirector
Tessellex Ltd.
Design and execution of optimal cross-platform translational
medicine programmes to define in-human mechanism of action and
identify therapeutic biomarkers.
Charles BradshawHead of Bioinformatics Core
The Gurdon InstituteUniversity of Cambridge
What can pharmaceutical R&D executives do to successfully lead
human genetics enabled R&D organizations?
Prof. Wim Van CriekingeCo-Founder BioLIzard
Next generation biomarkers: from omics to precision medicine
Bio-Courier Technology as Non-Viral Delivery System for Gene Therapy.
Suzanne Saffie-Siebert CEO
SiSaf Ltd.
GO TO MENU NEXT PAGEPREVIOUS PAGE
ROUNDTABLE TOPIC
TIME SLOT (*GMT)
ROUNDTABLE TOPIC
TIME SLOT (*GMT)
TIME SLOT (*GMT)
ROUNDTABLE TOPIC
TIME SLOT (*GMT)
SPONSOR ROUNDTABLE TOPIC
12:00 - 12:30
18:00 - 19:00
14:30 - 15:30
19:20 - 20:20LEARN MORE ABOUT OUR SPEAKERS
PROVENTAI N T E R N A T I O N A L
11
TRACK 8 TRANSLATIONAL MEDICINE & INFORMATICS
BIOINFORMATICS
Paul Agapow Health Informatics Director
AstraZeneca
How to Improve Drug Development and Clinical trials with Real World
Evidence.
Fred Jacobs CEO
TYG-Oncology
Predictive analytics: The leveraging of computational techniques to aide
in decision-making.
SPEAKER TBC TBC TBC
Data Science for translational research in Pharmaceutical industry.
Improving the efficiency of Clinical trials with real world data.
Chris Penkett Head of Pipelines NHSBTUniversity of Cambridge
GO TO MENU NEXT PAGEPREVIOUS PAGE
ROUNDTABLE TOPIC
TIME SLOT (*GMT)
ROUNDTABLE TOPIC
TIME SLOT (*GMT)
TIME SLOT (*GMT)
ROUNDTABLE TOPIC
TIME SLOT (*GMT)
SPONSOR ROUNDTABLE TOPIC
12:00 - 12:30
18:00 - 19:00
14:30 - 15:30
19:20 - 20:20LEARN MORE ABOUT OUR SPEAKERS
PROVENTAI N T E R N A T I O N A L
12
TRACK 9 ARTIFICIAL INTELLIGENCE / MACHINE LEARNING
BIOINFORMATICS
Steven Zimmer CEO
EPICOMBI Therapeutics Ltd.
Strategic partnership of AI startup and Pharma.
David Hamilton Associate Director, Clinical Development & Analytics
Novartis
Foundational concepts for good design thinking, intelligent adaption
and community adoption
SPEAKER TBC TBC TBC
AI in drug discovery: challenges and opportunities.
Tim Van den BulckeHead of Bioinformatics
Galapagos
GO TO MENU NEXT PAGEPREVIOUS PAGE
ROUNDTABLE TOPIC
TIME SLOT (*GMT)
ROUNDTABLE TOPIC
TIME SLOT (*GMT)
TIME SLOT (*GMT)
ROUNDTABLE TOPIC
TIME SLOT (*GMT)
SPONSOR ROUNDTABLE TOPIC
12:00 - 12:30
18:00 - 19:00
14:30 - 15:30
19:20 - 20:20LEARN MORE ABOUT OUR SPEAKERS
Using AI and Machine Learning to reduce time and increse the
productivity of drug discovery
PROVENTAI N T E R N A T I O N A L
13
TRACK 10 DATA INTEGRATION / DATA MINING
BIOINFORMATICS
Rodrigo Lopez Head of Web Prod.
Wellcome Trust Genome Campus
Using data analytics to drive innovation and value.
Vincent Lawton Chairman & CEO
Addex Therapeutics
The importance of data integration in Clinical Trials; accessibility to data
set for reproducibility and study expansion.
Hans ConstandtFounder
Ontoforce
How to integrate data into one consistent, accessible environment to
improve data quality and efficency.
Data integration solution, for the improvement of research.
Bonde Bhushan Head of IT-Eearly Solutions Innovation Development
UCB
GO TO MENU NEXT PAGEPREVIOUS PAGE
ROUNDTABLE TOPIC
TIME SLOT (*GMT)
ROUNDTABLE TOPIC
TIME SLOT (*GMT)
TIME SLOT (*GMT)
ROUNDTABLE TOPIC
TIME SLOT (*GMT)
SPONSOR ROUNDTABLE TOPIC
12:00 - 12:30
18:00 - 19:00
14:30 - 15:30
19:20 - 20:20LEARN MORE ABOUT OUR SPEAKERS
PROVENTAI N T E R N A T I O N A L
14
TRACK 11 DATA VISUALISATION
BIOINFORMATICS
Emma Laing Lead Bioinformatician
Eli Lilly
Bioimaging data analysis in disease diagnosis and data visualization in
large-scale biodata.
David Brown Head of Infrastructure
Genomics England Ltd.
Integration, Analysis and Visualisation of Biological Data.
SPEAKER TBC TBC TBC
How visualisation and analysis tools can better support R&D decision
making.
Making better informed decisions from visualisation and analytic tools.
SPEAKER TBC TBC TBC
GO TO MENU NEXT PAGEPREVIOUS PAGE
ROUNDTABLE TOPIC
TIME SLOT (*GMT)
ROUNDTABLE TOPIC
TIME SLOT (*GMT)
TIME SLOT (*GMT)
ROUNDTABLE TOPIC
TIME SLOT (*GMT)
SPONSOR ROUNDTABLE TOPIC
12:00 - 12:30
18:00 - 19:00
14:30 - 15:30
19:20 - 20:20LEARN MORE ABOUT OUR SPEAKERS
PROVENTAI N T E R N A T I O N A L
15
TRACK 12 BIG DATA / DATA MANAGEMENT
BIOINFORMATICS
Minauti Frost VP Digital Risk
GSK
M-L for real world: How can big data bring the future of AI into medicine.
Alvaro Costa CEO
Alkol Biotech
Big Data for the development of new crop varieties for the biobased
markets.
SPEAKER TBC TBC TBC
How to streamline and structure big data to build machine learning
models.
Breaking down barriers to AI adoption in health care.
Marcelo Garcia Former Medical Systems Head
Novartis
GO TO MENU NEXT PAGEPREVIOUS PAGE
ROUNDTABLE TOPIC
TIME SLOT (*GMT)
ROUNDTABLE TOPIC
TIME SLOT (*GMT)
TIME SLOT (*GMT)
ROUNDTABLE TOPIC
TIME SLOT (*GMT)
SPONSOR ROUNDTABLE TOPIC
12:00 - 12:30
18:00 - 19:00
14:30 - 15:30
19:20 - 20:20LEARN MORE ABOUT OUR SPEAKERS
PROVENTAI N T E R N A T I O N A L
16
2019 ATTENDEES p.1
GO TO MENU NEXT PAGEPREVIOUS PAGE
COMPANYABPIAIT Austrian Institute of Technology GmbHAlkol BiotechAmgenAmgenAmgenArtios PharmaAstraZenecaAstraZenecaAstraZenecaAstraZenecaAstraZenecaAstraZenecaAstraZenecaAstraZenecaBar Ilan UniversityBayer AGBiogenBiogenBiomedical Research Centre at Guy’s Hospital and King’s College LondonBiozentrum, University of BaselBluebird bioBlueprint MedicinesBoehringer Ingelheim Bridge Biotec LtdBrunel University LondonC4x DiscoveryC4x Discovery Coordination Centre for Clinical Trials (KKS)Debiopharm InternationalE Therapeutics PLCEli LillyEli LillyErasmus MCeTherapeuticsFraunhofer ITEM GalapagosGenomics EnglandGlaxoSmithKlineGlaxoSmithKline
JOB TITLE
Head of Health Data & OutcomesThematic CoordinatorCEOEuropean RWD leadProgramming Lead for Europe, Centre for Observational ResearchDirectorPrincipal Scientist, BioinformaticsGlobal Head of Health InformaticsHealth Informatics DirectorPrincipal ScientistPrincipal Data ScientistSenior Director, Knowledge ManagementAssociate Director, BioinformaticsAssociate Principal Informatics ScientistProgramme Manager, Clinical Information SharingProfessor/Director Clinical Development LeadHead of Computational ChemistryMedical Director, EU & Canada Medical Strategy & Execution LeadHead of Genomics Research Platform and Single Cell Facility and Senior Research FellowHead Research ITAssociate Director Medical AffairsInternational Head of Precision MedicineClinical Program LeadDirector / CEOSenior LecturerTarget Discovery Genetics Project LeaderVP Novel Target Biology & GenomicsDirectorVP Translational MedicineBusiness Development and Programme DirectorLead Senior BioinformaticianSenior BioinformaticianProfessorPrincipal Data ScientistGroup LeaderHead of BioinformaticsHead of Bioinformatics PartnershipsGlobal Head Computational Biology and Stats Scientific Leader
Glenmark PharmaceuticalsGoldsmiths, University of LondonGrünenthalGSKGSKGSKGSKGSKHiFiBioImmatics BiotechImperial College LondonImperial College LondonInflaRx InflaRxIO BiotechiOnctura SA IpsenIpsenJanssenJuno Therapeutics, a Celgene companyKarus TherapeuticsKing’s College LondonKymabLeo PharmaLondon South Bank UniversityMax Planck Institute for Biology of AgeingMedigene Immunotherapies GmbHMedImmuneMerckMerck KGaAMerck KGaAMerck KGaAMerck KGaAMerck Sharp & DohmeMerusMolecular Partners, AGMorphoSysMorphoSysNanna Therapeutics
Senior Vice President, Global Head of Translational SciencesProfessor of Cognitive ComputingScientific Director Senior Scientific DirectorSenior MetaData ManagerInterim Head of Human Genetics Computational BiologySenior MetaData ExpertScience Advisor Gene Therapy and Rare DiseaseEVP Business DevelopmentDirector, Clinical DevelopmentResearch FellowProfessor/ Director CISBIOCMOProgram Director Clinical Research & Development OncologyChief Medical OfficerChief Operating OfficerVice President Translational Sciences & Clinical Pharmacology Medical DirectorMedical Manager OncologySenior Vice President and Managing DirectorChief Operating Officer and Chief Scientific OfficerDirector of eResearchSenior Scientist (KY1005 Scientific Lead) , Transnational MedicinePrincipal ScientistProfessor, Head of Big Data and Informatics Research GroupHead of BioinformaticsDirectorVP Clinical RespiratoryDirector Cancer & Inflammation, Scientific Site Head Immuno-OncologyDirector Oncology BioinformaticsMarket Access Lead Oncology EMEADirector, Clinical Quality ManagementSenior Director, Head Biomarker Development & Validation StrategyDirector, R&D Analytics Executive Vice President and Chief Scientific OfficerVP, Head of Immuno-oncologyDirector, Program LeaderVice President & Head of CommercialDirector of Informatics
COMPANY JOB TITLE
BIOINFORMATICSBIOINFORMATICSONCOLOGY
ONCOLOGY &
PROVENTAI N T E R N A T I O N A L
17
2019 ATTENDEES p.2
GO TO MENUPREVIOUS PAGE
COMPANY
Nektar TherapeuticsNeovii Pharmaceuticals NovartisNovartis“Novartis “NovozymesOncoOneOncoQR MLOxford BioTherapeuticsOxford BioTherapeuticsPhilochemPierisPierre FabreProthenaQueen Mary UniversityRocheRocheRocheRocheRoche Roche Roche DiagnosticsRoche PharmaSandoz International
JOB TITLE
Vice President and Head of DiscoveryChief Scientific OfficerData Science Head MusculoskeletalHead of Medical Affairs OREMedical Systems Head - ICE, Global Medical AffairsHead of IT DepartmentCEOChief Scientific Officer and Managing DirectorDirector of Information Systems and BioinformaticsChief Executive OfficerGlobal Head of Precision MedicineDirector Immuno OncologyVice President – Head of Translational MedicineEU Medical Affairs headProfessor and Director, Centre for Translational Bioinformatics Global Head Strategic Alliances PREDiHead of Global BI Solution Center WelwynDigital Lead for Large Molecule ResearchDirector External Innovation, Oncology DiscoveryGlobal Medical DirectorGlobal Studies LeaderHead Data ManagementSenior LeaderHead Strategy and Novartis Collaborations
Sanofi
SanofiServierServierServier Deutschland GmbH ShireTakedaThemis BiosciencesTYG OncologyUCBUCBUCBUCLUniversität zu Lübeck, Medical Systems BiologyUniversity College LondonUniversity of BaselUniversity of BuckinghamUniversity of CambridgeUniversity of Halle-WittenbergUniversity of Leipzig University of LübeckUniversity of MunichUniversity of PlymouthVertex Pharmaceuticals
Sr Director, European Head of Medical Affairs for Oncology, Hematology and Solid Organ TransplantationMedical Manager Oncology GSAHead of Bioinformatics and Computational BiologyHead of Global Oncology Early Products StrategyDirector BU Oncology / HematologyGlobal Medical LeadScientific Informatics ArchitectHead ImmunotherapyChief Executive Officer and Co-Founder Director, Translational Bioinformatics, NeurosciencesHead of IT, New Medicines Innovation Senior Data Acquisition ManagerAcademic Lead of UCL GenomicsGroup LeaderProfessor of Bioinformatics and Computational BiologyProject HeadInterim Dean – School of ComputingHead of Bioinformatics CoreGroup LeaderDeputy HeadProfessor for Systems MedicinePrivate ProfessorProfessor in BioinformaticsDirector, Scientific Computing
COMPANY JOB TITLE
BIOINFORMATICSBIOINFORMATICSONCOLOGY
ONCOLOGY &